MTOR and breast cancer: GPR30 triggered PI3K/mTOR axis to elevate the extracellular secretion of HMGB1 (High mobility group box 1) in CAFs which led to the activation of the MEK/ERK axis in neighboring ERα-positive breast cancer cells and thereby induction of autophagy to accelerate tamoxifen resistance (46).